The Hubei provincial Drug and Instrument Procurement Platform has issued a notice regarding the implementation of the inter-provincial volume-based procurement (VBP) tender results for pacemakers. This move requires affected manufacturers to complete the necessary steps for winning bids maintenance and filing. Additionally, relevant manufacturing delivery companies and medical institutions are mandated to confirm their delivery relationships and make the appropriate arrangements.
Details of the Tendering Process and Results
The Guangdong Medicine Exchange had released details of the tendering for pacemakers in November of the previous year, which included Jiangxi, Hubei, Guangdong, and Guizhou. The winning results were announced in February 2023, with prices ranging from RMB 7,125 (USD 1,034) to RMB 172,979 (USD 25,124), reflecting an average price reduction of 43.09%. The tender saw seven foreign manufacturers and three domestic manufacturers securing spots, indicating a competitive and successful procurement process.
Implementation and Procurement Cycle
The implementation of the tender results commenced as of April 1, 2023, and is set to last until June 30, 2025. This procurement cycle provides a structured timeframe for the distribution and management of pacemakers, ensuring a steady supply to medical institutions within the specified regions.-Fineline Info & Tech
